Americas Small Cap Research Summary

This Barclays summary covers ratings and estimate changes for several Americas small-cap stocks including Certara, Hertz, and MBX Biosciences.

Key Takeaways

• 1.MBX Biosciences (MBX) shows competitive early data for its obesity candidate MBX 4291, with significant weight loss at 8 weeks.
• 2.Hertz (HTZ) continues to face liquidity and debt overhangs despite meeting 1Q EBITDA expectations and reaffirming margin guidance.
• 3.Certara (CERT) is undergoing a strategic reorganization to focus on AI and innovation, leading to a reduction in price target from $8.00 to $6.50.

Table of Contents

• Summary of Changes
• Publications Summary
• Consumer
• Healthcare
• Industrials
• Technology
• Analyst(s) Certification(s)
• Important Disclosures

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial